the reduced potential for cardiac toxicity of epirubicin versus doxorubicin has been shown both by functional assessment ( radionuclide cinecardioangiography ) and by histopathologic evaluation ( endomyocardial biopsies ) at equally myelosuppressive doses or at equal doses ( equimolar ) .
C0014582
epirubicin
C0013089
doxorubicin